Boman, Sol Erika
Fuentes, Stina
Nordenvall, Caroline
Martling, Anna
Chen, Lingjing
Glimelius, Ingrid
Neovius, Martin
Smedby, Karin E.
Eloranta, Sandra
Funding for this research was provided by:
The Swedish Cancer and Allergy foundation
Stockholm Cancer Society and supported by grants provided by the Regional Agreement on Medical Training and Clinical Research (ALF) between the Stockholm County Council and Karolinska Institutet
Radiumhemmets Forskningsfonder
The Swedish Cancer Society
Strategic Research Program in Epidemiology at Karolinska Institutet (3832/2010)
Karolinska Institute
Article History
Received: 11 September 2023
Accepted: 29 January 2024
First Online: 6 February 2024
Declarations
:
: I Glimelius received honoraria from Jansen Cilag and Takeda and participated in the evaluation of side effects from immunotherapy treatments developed by Lokon Pharma. K Ekström-Smedby has received research funding from Janssen Pharmaceuticals NV. For the remaining authors none were declared.